REPLY
22.2.2021 10:02:09 CET | Business Wire | Press release
The pandemic has accelerated the trend of adopting new interfaces in both consumer and professional fields, according to Reply’s new research “New Interfaces, Zero Interfaces” , based on Reply’s Trend SONAR proprietary data-driven platform.
The research explores the development prospects of state-of-the-art interfaces that are coming to prominence in this new normal by analysing significant studies, scientific articles and patents published in the last two years, while integrating them with relevant experiences from Reply customers.
Smartphones and their operating systems have been enabling completely new experiences for almost 15 years; now 5G, high-speed connectivity, and edge computing are set to provide a further boost for user interface technologies like wearables, smart speakers, 3D spatial interfaces, multimodal and brain-computer interfaces.
“Companies will develop more personalized and emotional interactions with customers, as well as new possibilities for the analysis and visualization of information,” commented Filippo Rizzante, CTO Reply. "Looking at the impacts of the pandemic on the interfaces we use today, there are two trends that more than others we are seeing growing: a wider demand for remote healthcare, and the need to reduce touch interfaces".
Voice is the fastest growing interface, thanks to its frequent use in daily life through smart speakers and cars. It is also increasingly being used for marketing purposes, allowing popular brands to literally speak directly to consumers – a much more intimate connection than the ones offered by traditional touchpoints.
Industries like pharmaceuticals, fashion, real estate, and travel are progressively implementing extended reality technologies through mobile apps or special headsets. Extended Reality is set to greatly enhance training and workplace collaboration, offering teams much better ways of meeting and sharing ideas and thoughts in both virtual and augmented realities.
Wearables are becoming steadily more relevant in the field of daily-use interfaces. Rings, glasses, and ‘hearables’ can be connected to smart assistants to help with daily life and monitor behaviour. Combined with next-gen smartwatches, these kind of wearables could become the first full-alternative, independent, consumer-ecosystem to the smartphone.
Gaze control and eye tracking will allow people to control, communicate and interact with machines based on eye movement patterns, fixations and pupil reaction. Brain-computer interface (BCI) technology is accelerating as well. The focus is still predominantly medical and scientific, however its diffusion into other areas is increasing, blurring the lines between computing and biology.
In the mobility industry , new interfaces will have a crucial role in the safety and the security of vehicle drivers and pedestrians, using new smart technologies to improve safety and communications with other road users. New interfaces will also make cars and trucks more customisable and predictive. Moreover, autonomous driving will enable greater development in entertainment and advertising within vehicles.
Retail-related interface development is experiencing seismic shifts as well, helping shoppers enjoy the benefits of physical shopping – tactile, sensory and social – in digital virtual spaces that enable frictionless and comfortable shopping while driving customer acquisition, retention and loyalty to new heights. The use of Artificial Intelligence-based and conversational interfaces will refine customisation down to the needs of the individual customer. AI and digital technologies allow for more personalisation for customers, from inspiration to tackling sizing and fitting issues in fashion retail.
With increasing sensor integration and natural embedding into the surrounding world, interfaces will be invisibly interwoven into everyday life and work environments, turning anything into an interface, seamlessly communicating with each other and expanding human cognition and senses.
For more insights download the full research “New Interfaces, Zero Interfaces” . This new research is part of the Reply Market Research series, including the recent “From Cloud to Edge” and “Rebooting Longevity” .
Reply
Reply [MTA, STAR: REY, ISIN: IT0005282865] specialises in the design and implementation of solutions based on new communication channels and digital media. As a network of highly specialised companies, Reply defines and develops business models enabled by the new models of AI, big data, cloud computing, digital media and the internet of things. Reply delivers consulting, system integration and digital services to organisations across the telecom and media; industry and services; banking and insurance; and public sectors. www.reply.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20210222005065/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Meiji Seika Pharma: Results from the Global Phase III Trial (Integral-2) of Nacubactam, a Novel β-Lactamase Inhibitor, Highlighted in The Lancet Microbe’s Coverage of ESCMID Global Congress 202617.7.2026 03:00:00 CEST | Press release
Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, President and Representative Director: Toshiaki Nagasato) today announced that results from the global Phase III trial (Integral-2) of nacubactam (Development Code: OP0595), a novel β-lactamase inhibitor, were highlighted in The Lancet Microbe’s coverage of ESCMID Global Congress 2026 (held in Munich, Germany). As highlighted in The Lancet Microbe’s coverage, the key findings presented by Meiji Seika Pharma at ESCMID Global Congress 2026 are as follows: The Integral-2 study (jRCT2031230076) is a global Phase III clinical trial that enrolled patients with complicated urinary tract infections, acute uncomplicated pyelonephritis, hospital-acquired bacterial pneumonia, ventilator-associated bacterial pneumonia, or complicated intra-abdominal infections caused by carbapenem-resistant Gram-negative bacteria (excluding Acinetobacter species). The study has achieved the prespecified study objectives. For the primary endpoint of overall treatme
Yoshihiro Shimamura Joins the Marché du Film’s “Investors Circle 2026” as an Invited Investor, Backing a New Feature Film17.7.2026 03:00:00 CEST | Press release
Shimamura Yoshihiro Film Production Co., Ltd. (Head office: Osaka, Japan; Representative Director: Yoshihiro Shimamura), a company active in film production and investment, today announced that Representative Director Yoshihiro Shimamura has decided to invest in an international feature film after being invited to the “Investors Circle 2026” — a distinction that reflects his standing as one of the field’s most highly regarded producers and investors. Hosted by the Marché du Film, the business arm of the Festival de Cannes and one of the world’s largest film markets, the Investors Circle is an invitation-only summit that connects a select group of private investors with high-end feature films during early-stage financing. Held in Cannes, France, May 16-17, 2026, it brings internationally acclaimed directors and producers together with investors around a curated slate of projects in development. During the summit, Shimamura attended private pitching sessions and, after individual meeting
Takeda’s Zasocitinib Demonstrates Consistent, High Rates of Skin Clearance Across the Body, Including Hard-to-Treat and High-Impact Sites, in Phase 3 Psoriasis Studies17.7.2026 00:00:00 CEST | Press release
On average, about 75% of patients with scalp psoriasis treated with zasocitinib achieved clear or almost clear skin at week 16 Approximately 70% of patients with palmoplantar disease treated with zasocitinib achieved clear or almost clear skin at week 16 Zasocitinib demonstrated statistically significant improvements in Nail Psoriasis Severity Index (NAPSI) versus placebo Results reinforce the potential of zasocitinib to deliver rapid and durable skin clearance, including in the hardest-to-treat areas, in a convenient once-daily pill Takeda (TSE:4502/NYSE:TAK) announced new data from the two pivotal Phase 3 studies of zasocitinib (TAK-279), a next-generation, highly selective and potent oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented at the 2026 American Academy of Dermatology (AAD) Innovation Academy, these secondary endpoint data show that zasocitinib demonstrated consistent and high rates of skin clearance across hard-to-
Merz Completes Inaugural €450 Million Schuldschein Loan Issuance16.7.2026 23:36:00 CEST | Press release
Debut transaction more than three times oversubscribed The Merz Group has successfully completed its first-ever Schuldschein loan issuance, placing a total volume of €450 million in the debt capital market – a multiple of three relating to the launch volume. The debut transaction was significantly oversubscribed and attracted strong interest from all investor groups. The proceeds were settled and paid out today. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260716926041/en/ Dr. Almuth Steinkühler, Chief Financial Officer Merz Group The transaction comprises both fixed- and floating-rate tranches with maturities of three, five, seven, and ten years. Around 50 German and international investors participated, representing a broad range of institutions, including private banks, German federal state-owned banks, public savings banks, cooperative banks, pension funds and occupational pension institutions. With the successful plac
The Estée Lauder Companies Appoints Madeleine Boyd as Senior Vice President, Global Brand Communications16.7.2026 22:22:00 CEST | Press release
The Estée Lauder Companies Inc. (NYSE: EL) today announced the appointment of Madeleine Boyd as Senior Vice President, Global Brand Communications, effective July 20, 2026. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260716738393/en/ Photo by Esteban La Tessa As part of the company’s continued efforts to strengthen how its brands better connect with consumers, Ms. Boyd will establish and lead a newly integrated Global Brand Communications team. In this role, she will ensure the company’s diverse portfolio is anchored by a cohesive enterprise communications strategy, while accelerating bold, consumer-first storytelling that drives earned media, cultural relevance, and brand desirability. She will also strengthen creator engagement, helping the company’s brands gain attention where culture is being shaped. Ms. Boyd brings extensive experience spanning brand strategy, communications, consumer engagement, and cultural insight
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom